This week's issue of the Journal of the Norwegian Medical Association is presenting a portrait interview of Mette Kalager, leader of the Clinical Effectiveness Group. Kalager reveals insights about early career struggles, recent acknowledgements and aims for the future.
News - Page 2
The Clinical Effectiveness Group is in the final round to be awarded status as a new Norwegian Centre of Excellence (SFF) 2016. In the event of an SFF-award the group will start up the Norwegian Institute of Cancer screening Evidence and Research (NICER). Watch the film about NICER!
The Clinical Effectiveness group has recently published an article in the journal «Gut» about the challenges in estimating risk of colorectal cancer among patients with IBD, and proposals on how to solve them.
The Clinical Effectiveness Research Group at the University of Oslo is publishing papers on clinical trials and observational research in leading medical journals. Topics of publication include cancer screening, with particular emphasis on breast cancer and colorectal cancer, endoscopy and epidemiologic methodology.
Mette Kalager publishes an article on concerns about data sharing in The New England Journal of Medicine. In the article, Kalager proposes solutions on how to make data sharing a success.
.jpg?alt=listing)
The first ever randomised controlled trial on colorectal cancer (CRC) screening with colonoscopy reveals significant differences between endoscopists' performances. Findings from the NordICC-study was published this week in JAMA Internal Medicine.
.jpg?alt=listing)
Despite compelling evidence for using carbon dioxide (CO2) to reduce patient pain after colonoscopy, most endoscopists worldwide still use air insufflation during colonoscopy. A new paper aims to encourage change and new standards.
The leading scientific journal «Endoscopy» has today released the first paper from the European Polyp Surveillance (EPoS) study group.
Professor Michael Bretthauer is awarded FRIPRO Toppforsk 2016. FRIPRO is a joint initiative between the research institutions and the Norwegian Research Council, with the purpose of supporting groups in the forefront of international research.
The University Hospital of North Norway (UNN) and the University of Tromsø (UiT) are now participants in what is described as the world's largest research project on bowel cancer EPoS according to the newspaper iTromsø.
A large portrait interview with Michael Bretthauer reveals insights about his early career in Norway, and how he had to perform a colonoscopy on a world-renowned medical researcher to convince him to join a large study on colonoscopy.
Endoscopic screening for gastrointestinal cancers has been introduced in many countries. Precise estimates of the magnitude of benefits and harms of endoscopic screening for cancer are a prerequisite for informed decision making for or against participation in screening for individuals in the target population.
After one year with preparations, the EPoS (European Polyp Surveillance Trial) trial has started patient recruitment. The EPoS study will include 30,000 patients over the next three years. Aim of the study is to find better surveillance intervals for patients with colorectal polyps.
The Clinical Effectiveness Research Group recently held a course in Medical Publishing hosted by the University of Bari in Italy. The course was a great success and the participants were satisfied with both the execution and the content of the course.
In the past years we have had a heated debate on the benefits and harms of mammography screening. In this review, the authors discuss the benefits and harms in light of findings from randomized trials, and from more recent observational studies performed in the era of modern diagnostics and treatment.
This review outlines the most current thinking regarding the effectiveness of colonoscopy as a screening tool. It also outlines key concepts to optimize its performance through robust quality assurance programmes and high-quality training. The review is published in GUT.
Screening may release new research funding to improve health service also in routine clinics. The article is published in the Scandinavian Journal of Gastroenterology.
Researchers have compared two different colonoscopy techniques with regard to patients’ experience of pain during colonoscopy.
High quality colonoscopy achieving accurate detection and removal of adenomas, is considered the key to screening efficacy. Results from a new study shows that teaching centre leaders in colonoscopy training improves important quality measures in screening colonoscopy.
A Norwegian study shows that a new type of polyp is associated with increased risk of colorectal cancer, but the polyp itself may not develop into cancer.
Guest researcher Michal Kaminski at the Institute of Health and Society received on October 19th an award for outstanding achievements within his field of research in his home country Poland. He is awarded for his work on colorectal cancer and screening.
Patients with polyps have a lower risk of death from colorectal cancer than previously assumed.
The NORCCAP- study (NORwegian Colorectal CAncer Prevention) including 100.000 participants shows that flexible sigmoidoscopy screening reduces the risk of colorectal cancer by 20 %. The results are published on August 13th in one of the most prestigious general medical journals; JAMA (Journal of the American Medical Association)
Two large research grants for the Clinical Effectiveness Research group
Dr. Kjetil Garborg was awarded with the Sørlandet Hospital Research Prize 2012